| 2021-02-08 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 3,842 0.004% | $116.80 | $448,749 | -19.67% | |
| 2021-02-05 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 704 0.0007% | $113.79 | $80,109 | -18.56% | |
| 2020-11-12 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 2,257 0.0024% | $90.74 | $204,807 | +6.08% | |
| 2020-08-05 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 2,257 0.0024% | $118.89 | $268,324 | -17.85% | |
| 2020-05-12 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 18,057 0.0198% | $114.94 | $2.08M | -8.73% | |
| 2020-04-24 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 1,934 0.0021% | $99.46 | $192,351 | +6.23% | |
| 2020-02-07 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 1,623 0.0017% | $103.33 | $167,702 | -1.41% | |
| 2020-02-06 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 1,395 0.0015% | $101.56 | $141,670 | -0.23% | |
| 2020-02-05 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 2,046 0.0022% | $103.02 | $210,779 | +0.33% | |
| 2019-07-30 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 44,356 0.0467% | $92.77 | $4.11M | +6.8% | |
| 2019-07-15 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 30,680 0.0334% | $87.50 | $2.68M | +15.5% | |
| 2019-07-11 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 100 0.0001% | $87.59 | $8,759 | +17.09% | |
| 2019-07-10 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 7,120 0.0078% | $87.63 | $623,958 | +15.3% | |
| 2019-06-18 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 2,100 0.0024% | $87.82 | $184,417 | +14.68% | |
| 2019-06-13 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 17,268 0.0186% | $82.62 | $1.43M | +16.75% | |
| 2019-06-03 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 3,435 0.0039% | $85.51 | $293,719 | +19.16% | |
| 2019-05-31 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 19,297 0.0212% | $85.02 | $1.64M | +15.36% | |
| 2019-05-24 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 17,486 0.0192% | $80.03 | $1.4M | +22.08% | |
| 2019-05-22 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 1,300 0.0014% | $80.03 | $104,037 | +22.03% | |
| 2019-05-16 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Development Officer | 731 0.0008% | $80.13 | $58,574 | +21.27% |